Literature DB >> 18677585

[Hypertension and the kidney].

Katharina Hohenstein1, Bruno Watschinger.   

Abstract

Hypertension and proteinuria are common risk factors for cardiovascular morbidity and mortality, as well as for the progression of renal disease. Renal functional impairment represents an independent cardiovascular risk factor by itself. Strict antihypertensive therapy and measures to maximally reduce proteinuria can substantially improve the prognosis of renal patients. This review summarizes current evidence for the role of hypertension and proteinuria with regard to renal and cardiovascular outcomes and for the importance of intensive antihypertensive and anti-proteinuric measures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677585     DOI: 10.1007/s10354-008-0558-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  56 in total

1.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  Treatment of diabetic nephropathy in its early stages.

Authors:  Giacomo Deferrari; Maura Ravera; Valeria Berruti
Journal:  Diabetes Metab Res Rev       Date:  2003 Mar-Apr       Impact factor: 4.876

3.  Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension.

Authors:  Larry Warmoth; Monette M Regalado; Jan Simoni; Ronald B Harrist; Donald E Wesson
Journal:  Am J Med Sci       Date:  2005-09       Impact factor: 2.378

Review 4.  Importance of blood pressure control in chronic kidney disease.

Authors:  Maura Ravera; Michela Re; Luca Deferrari; Simone Vettoretti; Giacomo Deferrari
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

5.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors: 
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

6.  Blood pressure predicts risk of developing end-stage renal disease in men and women.

Authors:  Masahiko Tozawa; Kunitoshi Iseki; Chiho Iseki; Kozen Kinjo; Yoshiharu Ikemiya; Shuichi Takishita
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

7.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

8.  Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Authors:  Roberto Minutolo; Luca De Nicola; Pasquale Zamboli; Paolo Chiodini; Giuseppe Signoriello; Clemente Toderico; Gennaro Arfè; Giuseppe Boschi; Ciro Brancati; Patrizia Iaccarino; Giuseppe Conte
Journal:  Am J Kidney Dis       Date:  2005-07       Impact factor: 8.860

9.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  1 in total

1.  Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  ZhongChi Xu; LiChao Qian; RuGe Niu; Ying Yang; ChunLing Liu; Xin Lin
Journal:  Front Med (Lausanne)       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.